Cyanotech (CYAN) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
13 Jun, 2025Executive summary
Net sales for Q2 FY2025 decreased 8.3% year-over-year to $5.8M, driven by lower packaged sales, partially offset by higher bulk and contract extraction sales.
Gross profit margin declined to 25.3% from 32.8% year-over-year due to higher bulk sales with lower margins and increased inventory costs.
Operating loss widened to $975K from $632K in the prior year quarter; net loss was $1.15M, or $(0.16) per share.
The company continues to face liquidity challenges, with substantial doubt about its ability to continue as a going concern.
Financial highlights
Six-month net sales rose 1.9% year-over-year to $11.7M, with bulk sales up 51% and packaged sales down 8%.
Six-month gross profit margin fell to 25.2% from 31.4% year-over-year.
Six-month operating loss was $2.0M, net loss $2.35M, or $(0.34) per share.
Cash at September 30, 2024 was $780K, with working capital of $550K, down from $2.0M at March 31, 2024.
Cash used in operations for the six months was $201K; financing activities provided $379K, mainly from related party credit draws.
Outlook and guidance
Focus remains on stabilizing production, rationalizing market channels, and leveraging core competencies.
Gross margin may face continued pressure from lower production volumes, input costs, and competition.
Emphasis on higher-margin consumer products and process improvements to stabilize costs.
Significant sales variability and unplanned cash outflows may occur; additional capital may be needed if downturn persists.
Latest events from Cyanotech
- Flat sales, lower margins, and new product launches amid cost pressures and secured financing.CYAN
Q4 20243 Feb 2026 - Net sales up 15% to $5.9M, but gross margin and liquidity pressures persist.CYAN
Q1 20252 Feb 2026 - Annual meeting to elect directors, approve equity plan, and ratify auditor, with governance focus.CYAN
Proxy Filing2 Dec 2025 - Key votes include director elections, a new equity plan, and auditor ratification for 2024.CYAN
Proxy Filing2 Dec 2025 - Director elections, auditor ratification, and triennial say-on-pay vote headline the agenda.CYAN
Proxy Filing2 Dec 2025 - Gross margin rose to 30.5% and net loss narrowed despite flat Q1 FY2026 revenue.CYAN
Q1 202623 Nov 2025 - Q2 sales up 19.3%, gross margin at 34.3%, operating income positive, but liquidity risks remain.CYAN
Q2 202618 Nov 2025 - Revenue up 5% and losses narrowed, but going concern risk remains due to liquidity and debt issues.CYAN
Q4 202520 Jun 2025 - Q3 sales rose 10.6% YoY, but ongoing losses and liquidity risks raise going concern doubts.CYAN
Q3 20255 Jun 2025